ARTICLE | Clinical News
Orteronel: Phase III started
November 15, 2010 8:00 AM UTC
Takeda's Millennium Pharmaceuticals Inc. subsidiary began a double-blind, international Phase III trial to compare TAK-700 plus prednisone vs. placebo plus prednisone in about 1,450 chemotherapy-naïv...